Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging
Tau PET identifies grey matter atrophy in retired athletes
By
Will Morton
Flortaucipir PET imaging is able to identify neuropathological brain changes in retired contact sport athletes at risk of neurodegeneration.
July 24, 2024
PET/MRI superior to PET/CT in cancer patients
By
Will Morton
FDG-PET/MRI is comparable or superior in diagnostic performance to FDG-PET/CT across a range of cancers and endpoints.
July 18, 2024
FAPI-SPECT reveals damage to myocardium after heart attack
By
Will Morton
Technetium-99m (Tc-99m) FAPI-SPECT shows promise as a tool for assessing cellular and structural changes in the myocardium after heart attack.
July 16, 2024
Bone marrow disorders associated with SARs in Lutathera patients
By
Will Morton
Pretreatment bone marrow disorders may predict which patients are at risk for severe adverse reactions (SARs) when treated with lutetium-177 DOTATATE.
July 15, 2024
The rise of theranostics: Part 5 -- Advice from center administrators
By
Liz Carey
Want to launch theranostics at your hospital and cancer center? An SNMMI 2024 session provided key planning steps.
July 12, 2024
LAFOV PET/CT feasible in infants with neuroblastoma
By
Will Morton
Long axial field-of-view (LAFOV) PET/CT scanners offer shorter procedure times and avoid the need for sedation or general anesthesia when imaging young children with neuroblastoma.
July 9, 2024
Swiss team produces 1st 3D PET/MRI image
By
Will Morton
Researchers at the University of Zurich in Switzerland say they have produced the first cinematically rendered image from a patient based on a standard clinical F-18 FDG-PET/MRI scan.
July 5, 2024
FDG-PET/CT improves management of patients with head and neck cancer
By
Will Morton
FDG-PET/CT imaging can reduce unnecessary surgeries in patients to remove residual neck cancer after they have undergone chemoradiotherapy.
July 2, 2024
PSMA-PET superior to MRI in phase II prostate cancer trial
By
Will Morton
PET/CT imaging with a new radiotracer is superior to MRI prior to surgery in men with intermediate-risk and high-risk prostate cancer.
July 1, 2024
New guideline covers theranostics in brain tumors
By
Will Morton
U.S. and European experts have proposed a joint practice guideline for use in nuclear medicine on diagnostics and therapy (theranostics) of meningiomas.
June 21, 2024
FCH-PET/CT superior to MIBI-SPECT/CT for guiding parathyroid surgery
By
Will Morton
F-18 fluorocholine (FCH) PET/CT could be a first-line technique over technetium-99m sestamibi SPECT/CT for imaging parathyroid tumors prior to surgery.
June 20, 2024
PET sheds light on opioid addiction treatments
By
Will Morton
PET imaging shows different brain activity in people taking methadone or buprenorphine for opioid use disorder (OUD).
June 19, 2024
Page 1 of 595
Next Page